ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC reported 262 US-listed holdings worth $2.11 billion in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Abivax SA (11.4%), Protagonist Therapeutics, Inc. (5.6%) and Roivant Sciences Ltd. (5.3%). Against the quarter before, it opened 43 positions, added to 96, trimmed 64 and sold out of 72.
Reported holdings$2.11B+28.0% on Q1 2026
Positions262-29 on Q1 2026
The largest ten42.2%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
OpenedAdded toHeldTrimmed
The 14 largest of its 262 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 43Added 96Held 59Trimmed 64Sold out 72
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 43
- Editas Medicine, Inc. EDIT$28.8 million
- Vor Biopharma Inc. VOR$12.5 million
- Sensei Biotherapeutics Inc. FTH$9.0 million
- Ascendis Pharma A/s ASND$7.6 million
- Amanat Acquisition Corp. AMAN$7.6 million
- Research Alliance Corp Iii Ord Shs Cl A RACC$7.0 million
- Relay Therapeutics Inc. RLAY$6.7 million
- Disciplined Growth DGACU$5.0 million
and 35 more in the table below
Added to 96
- Abivax SA ABVX+410,684 shares · +29%
- Agios Pharmaceuticals Inc. AGIO+1.1 million shares · +816%
- SPDR S&P 500 SPY+53,147 shares · +70%
- Zai Lab Limited ZLAB+1.9 million shares · +136%
- Praxis Precision Medicines I PRAX+72,753 shares · +4850%
- Insmed Inc. INSM+193,128 shares · +546%
- Enanta Pharmaceuticals Inc. ENTA+1.3 million shares · +2518%
- Rallybio Corp. Com RLYB+905,817 shares · +4411%
and 88 more in the table below
Trimmed 64
- Denali Therapeutics Inc. DNLI-842,375 shares · -45%
- Cytokinetics Inc. CYTK-174,649 shares · -28%
- Immunovant Inc. IMVT-348,294 shares · -13%
- Maplight Therapeutics Inc. MPLT-348,412 shares · -93%
- Sanofi SNY-259,839 shares · -82%
- Replimune Group, Inc. REPL-927,203 shares · -59%
- Amylyx Pharmaceuticals Inc. AMLX-506,226 shares · -51%
- Arbutus Biopharma Corp. ABUS-1.9 million shares · -60%
and 56 more in the table below
Sold out of 72
- Terns Pharmaceuticals Inc. TERN$48.2 million last quarter
- Beam Therapeutics Inc. BEAM$34.5 million last quarter
- Scholar Rock Holding Corporation SRRK$20.0 million last quarter
- Vertex Pharmaceuticals Inc. VRTX$6.7 million last quarter
- Viridian Therapeutics Inc. VRDN$6.0 million last quarter
- Ascendis Pharma A/s ASND$5.7 million last quarter
- Eli Lilly & Co. LLY$4.7 million last quarter
- Dianthus Therapeutics Inc. DNTH$4.6 million last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Abivax SA ABVX | 1,804,703 | $240.5 million | 11.39% | +410,684 |
| Protagonist Therapeutics, Inc. PTGX | 960,863 | $117.8 million | 5.58% | -33,256 |
| Roivant Sciences Ltd. ROIV | 3,157,008 | $111.7 million | 5.29% | -128,898 |
| SPDR S&P 500 SPY | 129,087 | $96.4 million | 4.56% | +53,147 |
| Immunovant Inc. IMVT | 2,330,716 | $89.8 million | 4.25% | -348,294 |
| Zai Lab Limited ZLAB | 3,369,034 | $64.0 million | 3.03% | +1,943,667 |
| Agios Pharmaceuticals Inc. AGIO | 1,288,053 | $47.8 million | 2.26% | +1,147,381 |
| Crinetics Pharmaceuticals in CRNX | 1,222,080 | $45.7 million | 2.17% | +82,749 |
| Ea Series Trust BOXX | 337,125 | $39.5 million | 1.87% | no change |
| Cytokinetics Inc. CYTK | 457,907 | $39.0 million | 1.85% | -174,649 |
| Septerna Inc. SEPN | 940,747 | $31.5 million | 1.49% | -149,071 |
| Anteris Technologies Global AVR | 3,145,096 | $31.0 million | 1.47% | -644,036 |
| Editas Medicine, Inc. EDIT | 8,889,000 | $28.8 million | 1.36% | new |
| Denali Therapeutics Inc. DNLI | 1,029,080 | $26.5 million | 1.25% | -842,375 |
| Spyre Therapeutics Inc. SYRE | 283,982 | $25.2 million | 1.19% | -54,341 |
| Vir Biotechnology, Inc. VIR | 2,456,677 | $25.0 million | 1.19% | -288,037 |
| Praxis Precision Medicines I PRAX | 74,253 | $24.9 million | 1.18% | +72,753 |
| Insmed Inc. INSM | 228,520 | $24.4 million | 1.15% | +193,128 |
| Celldex Therapeutics Inc. CLDX | 619,542 | $23.1 million | 1.09% | +191,726 |
| Viking Therapeutics Inc. VKTX | 574,038 | $22.4 million | 1.06% | +346,321 |
| Taysha Gene Therapies Inc. TSHA | 3,040,466 | $20.7 million | 0.98% | +61,037 |
| Monopar Therapeutics Inc. MNPR | 217,595 | $20.1 million | 0.95% | -46,683 |
| Ovid Therapeutics Inc. OVID | 7,417,479 | $20.0 million | 0.94% | +2,873,366 |
| Enliven Therapeutics Inc. ELVN | 387,718 | $19.7 million | 0.93% | +58,178 |
| Enanta Pharmaceuticals Inc. ENTA | 1,344,510 | $19.6 million | 0.93% | +1,293,153 |
| Nektar Therapeutics NKTR | 244,184 | $17.0 million | 0.81% | +82,932 |
| Inspire Medical Systems, Inc. INSP | 374,617 | $16.7 million | 0.79% | -30,580 |
| Revolution Medicines, Inc. RVMD | 87,509 | $16.4 million | 0.78% | -46,384 |
| Establishment Labs Holdings In ESTA | 185,619 | $15.9 million | 0.75% | -27,854 |
| Prothena Corp. PLC PRTA | 1,554,535 | $15.2 million | 0.72% | -26,908 |
| Rhythm Pharmaceuticals Inc. RYTM | 136,158 | $15.1 million | 0.72% | -75,292 |
| Inhibikase Therapeutics Inc. IKT | 7,387,205 | $15.0 million | 0.71% | +780,633 |
| Uniqure NV QURE | 324,672 | $15.0 million | 0.71% | +248,466 |
| Rallybio Corp. Com RLYB | 926,352 | $14.8 million | 0.70% | +905,817 |
| Regeneron Pharmaceuticals, Inc. REGN | 22,208 | $13.8 million | 0.66% | +10,054 |
| Inventiva SA IVA | 3,606,656 | $13.6 million | 0.65% | +1,432,258 |
| Sutro Biopharma Inc. STRO | 404,014 | $13.4 million | 0.64% | -120,427 |
| Ionis Pharmaceuticals Inc. IONS | 166,286 | $13.2 million | 0.62% | +5,948 |
| Bridgebio Pharma Inc. BBIO | 176,689 | $13.2 million | 0.62% | +82,397 |
| Sarepta Therapeutics, Inc. SRPT | 730,649 | $13.1 million | 0.62% | +468,591 |
| Cytomx Therapeutics Inc. CTMX | 3,365,118 | $12.6 million | 0.60% | -45,072 |
| Vor Biopharma Inc. VOR | 680,626 | $12.5 million | 0.59% | new |
| SPDR Ser Trust BIL | 135,585 | $12.4 million | 0.59% | no change |
| Equillium Inc. EQ | 3,758,569 | $12.0 million | 0.57% | +31,910 |
| Adlai Nortye Ltd ANL | 1,017,805 | $11.7 million | 0.55% | +899,896 |
| Eliem Therapeutics Inc. CLYM | 822,649 | $10.7 million | 0.51% | +224,987 |
| Helix Acquisition Corp. III HLXC | 1,000,000 | $10.6 million | 0.50% | no change |
| Zura Bio Ltd ZURA | 1,759,295 | $10.4 million | 0.49% | +1,128,892 |
| Onkure Therapeutics Inc OKUR | 2,238,684 | $10.2 million | 0.48% | -196,257 |
| Maze Therapeatics MAZE | 339,276 | $10.1 million | 0.48% | +289,181 |
| Xenon Pharmaceuticals Inc. XENE | 166,550 | $10.1 million | 0.48% | -62,349 |
| Teva Pharmaceutical Industries Ltd. TEVA | 277,848 | $9.4 million | 0.45% | +9,457 |
| Urogen Pharma Ltd URGN | 252,395 | $9.3 million | 0.44% | -143,064 |
| Sensei Biotherapeutics Inc. FTH | 361,010 | $9.0 million | 0.43% | new |
| Amylyx Pharmaceuticals Inc. AMLX | 494,378 | $8.9 million | 0.42% | -506,226 |
| DBV Technologies S A DBVT | 528,295 | $8.7 million | 0.41% | -484,571 |
| Savara Inc. SVRA | 1,403,409 | $8.6 million | 0.41% | -61,126 |
| Vaxcyte Inc. PCVX | 146,034 | $8.5 million | 0.40% | -113,103 |
| CG Oncology Inc. CGON | 118,664 | $8.4 million | 0.40% | -67,035 |
| Mineralys Therapeutics Inc. MLYS | 298,886 | $8.1 million | 0.38% | +144,200 |
| Ascendis Pharma A/s ASND | 28,604 | $7.6 million | 0.36% | new |
| Amanat Acquisition Corp. AMAN | 750,000 | $7.6 million | 0.36% | new |
| Nurix Therapeutics Inc. NRIX | 313,236 | $7.6 million | 0.36% | +257,166 |
| Biohaven Ltd BHVN | 501,687 | $7.5 million | 0.35% | +456,910 |
| Prime Medicine Inc. PRME | 1,997,552 | $7.4 million | 0.35% | +24,270 |
| Perceptive Cap Solutions Cor PCSC | 674,695 | $7.3 million | 0.35% | +175,114 |
| Ocuphire Pharma Inc. IRD | 1,783,781 | $7.3 million | 0.35% | -65,223 |
| Lexeo Therapeutics Inc. LXEO | 1,565,950 | $7.3 million | 0.35% | +98,600 |
| Galecto Inc. DMRA | 280,000 | $7.3 million | 0.34% | +1,000 |
| Replimune Group, Inc. REPL | 655,784 | $7.3 million | 0.34% | -927,203 |
| Athira Pharma Inc. LONA | 777,100 | $7.1 million | 0.34% | +49,619 |
| Korro Bio Inc. KRRO | 540,054 | $7.1 million | 0.34% | no change |
| Research Alliance Corp Iii Ord Shs Cl A RACC | 650,000 | $7.0 million | 0.33% | new |
| Inflarx NV IFRX | 3,000,000 | $6.7 million | 0.32% | +2,841,729 |
| Relay Therapeutics Inc. RLAY | 358,333 | $6.7 million | 0.32% | new |
| Janux Therapeutics Inc. JANX | 420,881 | $6.5 million | 0.31% | +122,335 |
| Pliant Therapeutics Inc. PLRX | 5,509,724 | $6.3 million | 0.30% | +2,924,598 |
| Aadi Bioscience Inc. WHWK | 1,341,394 | $6.1 million | 0.29% | +1,212,891 |
| Krystal Biotech, Inc. KRYS | 16,420 | $6.1 million | 0.29% | -3,594 |
| Arbutus Biopharma Corp. ABUS | 1,268,147 | $6.1 million | 0.29% | -1,865,028 |
| Pfizer Inc. PFE | 252,400 | $6.1 million | 0.29% | +175,000 |
| Brighthouse Financial, Inc. BHF | 95,523 | $6.0 million | 0.29% | no change |
| Edgewise Therapeutics Inc. EWTX | 143,199 | $5.8 million | 0.28% | +52,600 |
| Alector Inc. ALEC | 2,883,583 | $5.8 million | 0.27% | +1,833,583 |
| Fulcrum Therapeutics Inc. FULC | 1,565,029 | $5.7 million | 0.27% | +1,434,469 |
| Arrowhead Pharmaceuticals, Inc. ARWR | 69,800 | $5.7 million | 0.27% | -500 |
| Acumen Pharmaceuticals Inc. ABOS | 2,111,334 | $5.6 million | 0.27% | -45,000 |
| Oaktree Acquisition Corp. III | 516,482 | $5.6 million | 0.27% | no change |
| Globus Medical Inc. GMED | 70,100 | $5.5 million | 0.26% | +50,000 |
| Monte Rosa Therapeutics Inc. GLUE | 216,752 | $5.2 million | 0.25% | +1,000 |
| Disciplined Growth DGACU | 500,000 | $5.0 million | 0.24% | new |
| Bhav Acquisition Corp. BHAVU | 495,000 | $5.0 million | 0.24% | no change |
| Danaher Corp. DHR | 25,932 | $4.9 million | 0.23% | -5,000 |
| Boundless Bio Inc. BOLD | 1,968,216 | $4.9 million | 0.23% | new |
| Avalyn Pharma Inc. AVLN | 146,447 | $4.8 million | 0.23% | new |
| Ars Pharmaceuticals Inc. SPRY | 600,999 | $4.8 million | 0.23% | -760,537 |
| Atai Beckley NV ATAI | 913,242 | $4.8 million | 0.23% | no change |
| Prelude Therapeutics Inc. PRLD | 900,900 | $4.8 million | 0.23% | +748,075 |
| Jatt II Acquisition Corp. JATT | 417,724 | $4.7 million | 0.22% | new |
| Aileron Therapeutics Inc. RNTX | 4,500,000 | $4.7 million | 0.22% | new |
| Pepgen Inc. PEPG | 2,591,085 | $4.7 million | 0.22% | +983,447 |
| Contineum Therapeutics Inc. CTNM | 278,961 | $4.6 million | 0.22% | +2,300 |
| Perspective Therapeutics Inc CATX | 1,210,117 | $4.1 million | 0.20% | +460,782 |
| Apogee Therapeutics Inc. APGE | 31,000 | $4.1 million | 0.19% | new |
| Newamsterdam Pharma Company NAMS | 118,623 | $4.0 million | 0.19% | no change |
| Corbus Pharmaceuticals Hldgs CRBP | 421,787 | $4.0 million | 0.19% | +90,006 |
| Biogen Inc. BIIB | 17,900 | $3.9 million | 0.18% | +6,900 |
| Xencor Inc. XNCR | 232,560 | $3.7 million | 0.18% | +138,895 |
| Silence Therapeutics PLC SLN | 338,373 | $3.7 million | 0.18% | +166,216 |
| Spruce Biosciences Inc. SPRB | 67,717 | $3.7 million | 0.17% | +9,117 |
| Pharvaris N V PHVS | 105,528 | $3.6 million | 0.17% | no change |
| Engene Therapeut ENGN | 2,104,986 | $3.6 million | 0.17% | new |
| Palisade Bio Inc. PALI | 1,726,662 | $3.6 million | 0.17% | -538,183 |
| Protara Therapeutics Inc. TARA | 940,512 | $3.6 million | 0.17% | no change |
| Sagimet Biosciences Inc. SGMT | 437,500 | $3.4 million | 0.16% | new |
| Beigene, Ltd ONC | 11,701 | $3.3 million | 0.16% | no change |
| Invivyd Inc. IVVD | 3,807,427 | $3.3 million | 0.16% | -15,000 |
| Tenax Therapeutics Inc. TENX | 220,462 | $3.2 million | 0.15% | +7,000 |
| Zentalis Pharmaceuticals Inc. ZNTL | 652,750 | $3.2 million | 0.15% | +508,114 |
| Relmada Therapeutics Inc. RLMD | 451,918 | $3.1 million | 0.15% | no change |
| Delcath Sys Inc. DCTH | 224,385 | $2.8 million | 0.13% | no change |
| Biomarin Pharmaceutical Inc. BMRN | 49,000 | $2.8 million | 0.13% | +30,800 |
| Summit Therapeutics Inc. SMMT | 191,869 | $2.8 million | 0.13% | +100,000 |
| Keros Therapeutics Inc. KROS | 246,818 | $2.6 million | 0.13% | +149,500 |
| Eledon Pharmaceuticals Inc. ELDN | 647,812 | $2.6 million | 0.12% | -326,609 |
| Sanofi SNY | 57,100 | $2.4 million | 0.12% | -259,839 |
| American Exceptionalism Acqu AEXA | 205,408 | $2.4 million | 0.11% | -152,131 |
| Tango Therapeutics Inc. TNGX | 76,761 | $2.4 million | 0.11% | +26,761 |
| Intuitive Surgical Inc. ISRG | 6,030 | $2.4 million | 0.11% | +4,200 |
| Inovio Pharmaceuticals Inc. INO | 2,143,910 | $2.4 million | 0.11% | +673,802 |
| Omniab, Inc. OABI | 947,412 | $2.3 million | 0.11% | +242,222 |
| Capricor Therapeutics Inc. CAPR | 90,593 | $2.2 million | 0.10% | no change |
| Bright Minds Biosciences Inc. DRUG | 30,300 | $2.1 million | 0.10% | -3,600 |
| Oruka Therapeutics Inc. ORKA | 20,840 | $2.0 million | 0.09% | no change |
| Vyne Therapeutics Inc. VYNE | 2,950,000 | $1.9 million | 0.09% | +1,886,101 |
| McKesson Corp. MCK | 2,500 | $1.9 million | 0.09% | +1,300 |
| Lexicon Pharmaceuticals Inc. LXRX | 750,000 | $1.8 million | 0.09% | no change |
| Corvus Pharmaceuticals Inc. CRVS | 117,101 | $1.7 million | 0.08% | +29,200 |
| Cue Biopharma Inc. Com CUE | 55,193 | $1.7 million | 0.08% | new |
| Satellos Bioscience Inc. MSLE | 222,555 | $1.7 million | 0.08% | no change |
| Kiniksa Pharmaceuticals Intl KNSA | 26,913 | $1.7 million | 0.08% | no change |
| Connect Biopharma Hldgs Ltd CNTB | 700,000 | $1.7 million | 0.08% | -42,400 |
| Cohen Circle Acquisit Corp. I CCIIU | 150,000 | $1.6 million | 0.07% | no change |
| Rocket Pharmaceuticals Inc. RCKT | 435,500 | $1.5 million | 0.07% | +3,000 |
| First Tracks Biotherapeutics TRAX | 71,910 | $1.4 million | 0.07% | new |
| Evommune Inc. EVMN | 104,035 | $1.4 million | 0.07% | -80,027 |
| C4 Therapeutics Inc. CCCC | 291,957 | $1.4 million | 0.06% | +248,957 |
| Biocryst Pharmaceuticals Inc. BCRX | 133,000 | $1.3 million | 0.06% | +28,000 |
| Supernus Pharmaceuticals, Inc. SUPN | 27,842 | $1.3 million | 0.06% | -1,800 |
| Novo Nordisk A/S NVO | 27,000 | $1.3 million | 0.06% | -6,000 |
| Avantor, Inc. AVTR | 130,000 | $1.3 million | 0.06% | +50,000 |
| Inmed Pharmaceuticals Inc. INM | 800,000 | $1.2 million | 0.06% | new |
| Promis Neurosciences Inc. PMN | 92,850 | $1.2 million | 0.06% | -2,500 |
| Artiva Biotherapeutics Inc. ARTV | 118,624 | $1.2 million | 0.05% | new |
| Tenaya Therapeutics Inc. TNYA | 1,555,500 | $1.1 million | 0.05% | +47,700 |
| Alx Oncology Holdings Inc. ALXO | 533,660 | $1.1 million | 0.05% | new |
| Alexandria Real Estate Equities, Inc. ARE | 19,500 | $1.0 million | 0.05% | no change |
| Selecta Biosciences, Inc. RNAC | 98,877 | $1.0 million | 0.05% | new |
| Cyclerion Therapeutics Inc. CYCN | 298,757 | $1.0 million | 0.05% | new |
| Electronic Arts Inc EA | 4,936 | $1.0 million | 0.05% | no change |
| BioNTech SE BNTX | 10,600 | $986,330 | 0.05% | +600 |
| Acadia Pharmaceuticals Inc. ACAD | 38,955 | $985,562 | 0.05% | new |
| Dyne Therapeutics Inc. DYN | 42,821 | $951,054 | 0.05% | -4,642 |
| Maplight Therapeutics Inc. MPLT | 26,497 | $949,652 | 0.04% | -348,412 |
| Structure Therapeutics Inc. GPCR | 17,500 | $939,225 | 0.04% | new |
| Wave Life Sciences Ltd WVE | 160,000 | $929,600 | 0.04% | +115,100 |
| Aura Biosciences Inc. AURA | 130,152 | $924,079 | 0.04% | new |
| Churchill Cap Corp. Xi CCXI | 50,000 | $872,500 | 0.04% | new |
| Kazia Therapeutics Ltd KZIA | 61,550 | $866,624 | 0.04% | new |
| Nuvalent Inc. NUVL | 6,942 | $857,337 | 0.04% | no change |
| Larimar Therapeutics Inc. LRMR | 272,745 | $831,872 | 0.04% | +220,000 |
| Vera Therapeutics Inc. VERA | 18,322 | $786,197 | 0.04% | +2,289 |
| Adagio Med Hldgs Inc. ADGM | 1,205,447 | $785,469 | 0.04% | no change |
| Atrium Therapeutics Inc. RNA | 57,688 | $775,904 | 0.04% | no change |
| Therapeuticsmd Inc. Com New TXMD | 342,447 | $756,808 | 0.04% | +133,237 |
| Ideaya Biosciences Inc. IDYA | 20,000 | $745,400 | 0.04% | no change |
| Si-Bone Inc. SIBN | 45,000 | $734,400 | 0.03% | +32,420 |
| Royalty Pharma PLC RPRX | 12,500 | $700,875 | 0.03% | +7,500 |
| Evolus Inc. EOLS | 100,000 | $694,000 | 0.03% | +44,141 |
| Ibio Inc. Com IBIO | 375,531 | $657,179 | 0.03% | -94,347 |
| Forward Air Corp. FWRD | 48,241 | $651,736 | 0.03% | -30,000 |
| Geron Corp. GERN | 505,817 | $647,446 | 0.03% | +305,817 |
| Stryker Corp. SYK | 2,000 | $629,680 | 0.03% | new |
| Iovance Biotherapeutics Inc. IOVA | 146,090 | $607,734 | 0.03% | new |
| Macrogenics Inc. MGNX | 129,822 | $599,778 | 0.03% | +89,822 |
| Gilead Sciences, Inc. GILD | 4,648 | $587,228 | 0.03% | -1,703 |
| Natera Inc Com NTRA | 2,147 | $582,803 | 0.03% | no change |
| Seaport Therapeutics Inc. SPTX | 26,000 | $564,720 | 0.03% | new |
| Assembly Biosciences Inc. ASMB | 20,447 | $561,884 | 0.03% | +500 |
| Cybin Inc. HELP | 81,278 | $537,248 | 0.03% | +50,000 |
| Benitec Biopharma Inc. BNTC | 40,000 | $535,200 | 0.03% | +22,500 |
| Polypid Ltd PYPD | 103,950 | $528,066 | 0.03% | no change |
| Pulmonx Corp. LUNG | 404,497 | $525,846 | 0.02% | +30,000 |
| Moonlake Immunotherapeutics MLTX | 27,000 | $525,690 | 0.02% | -430,137 |
| Globa Terra Acquisition Cor | 50,000 | $519,500 | 0.02% | no change |
| Traws Pharma Inc. TRAW | 597,729 | $504,065 | 0.02% | +443,631 |
| Wisdomtree Trust USFR | 10,000 | $503,500 | 0.02% | no change |
| Tectonic Therapeutic Inc. TECX | 14,501 | $498,472 | 0.02% | +1,500 |
| Madrigal Pharmaceuticals Inc. MDGL | 895 | $480,570 | 0.02% | no change |
| Arvinas Inc. ARVN | 57,591 | $478,581 | 0.02% | no change |
| Orthopediatrics Corp. KIDS | 25,000 | $478,250 | 0.02% | +5,155 |
| Cogent Biosciences Inc. COGT | 12,200 | $472,140 | 0.02% | new |
| Phathom Pharmaceuticals Inc. PHAT | 42,900 | $465,465 | 0.02% | no change |
| Mirum Pharmaceuticals Inc. MIRM | 3,900 | $456,573 | 0.02% | -2,300 |
| Kiora Pharmaceuticals Inc. KPRX | 167,941 | $441,685 | 0.02% | no change |
| Kura Oncology Inc. KURA | 40,000 | $438,800 | 0.02% | no change |
| Context Therapeutics Inc. CNTX | 750,969 | $415,962 | 0.02% | +399,875 |
| iShares Trust STIP | 4,000 | $408,640 | 0.02% | new |
| Kalaris Therapeutics Inc KLRS | 100,000 | $407,000 | 0.02% | no change |
| Bicara Therapeutics Inc. BCAX | 13,705 | $406,901 | 0.02% | no change |
| Merck & Co., Inc. MRK | 3,140 | $403,490 | 0.02% | no change |
| Neumora Therapeutics Inc. NMRA | 210,000 | $357,000 | 0.02% | +176,900 |
| Irhythm Technologies Inc. IRTC | 3,000 | $356,850 | 0.02% | new |
| Achieve Life Sciences Inc. ACHV | 53,800 | $351,314 | 0.02% | +6,000 |
| Alibaba Group Holding Limited BABA | 3,578 | $343,416 | 0.02% | no change |
| WW Intl Inc. WW | 21,300 | $340,374 | 0.02% | -36,400 |
| CNS Pharmaceuticals Inc CNSP | 70,000 | $334,600 | 0.02% | new |
| Crescent Biopharma Inc. CBIO | 18,275 | $328,950 | 0.02% | -31,998 |
| Boston Scientific Corp. BSX | 7,500 | $320,100 | 0.02% | -2,500 |
| Altimmune, Inc. (alt) ALT | 102,823 | $312,582 | 0.01% | new |
| Verastem Inc. VSTM | 75,800 | $289,556 | 0.01% | +4,700 |
| AN2 Therapeutics Inc. ANTX | 58,808 | $284,631 | 0.01% | +44,947 |
| Journey Medical Corp. (derm) DERM | 39,517 | $279,780 | 0.01% | new |
| Procap Acquisition Corp. PCAPU | 26,940 | $279,368 | 0.01% | no change |
| PMV Pharmaceuticals Inc. PMVP | 201,008 | $269,351 | 0.01% | -30,000 |
| Compass Therapeutics Inc. CMPX | 122,132 | $267,469 | 0.01% | -16,868 |
| JD.com, Inc. JD | 10,000 | $254,800 | 0.01% | no change |
| Rezolute Inc. RZLT | 48,679 | $253,131 | 0.01% | -10,000 |
| Anaptysbio Inc. ANAB | 3,698 | $249,615 | 0.01% | no change |
| Neurogene Inc. NGNE | 7,800 | $245,310 | 0.01% | new |
| iShares Trust IHI | 4,900 | $242,109 | 0.01% | new |
| Rxsight Inc. RXST | 50,000 | $241,000 | 0.01% | +6,750 |
| Coya Therapeutics Inc. COYA | 40,900 | $239,265 | 0.01% | no change |
| Bicycle Therapeutics PLC BCYC | 50,638 | $214,705 | 0.01% | -20,660 |
| Cantor Equity Partners Vi in CEPS | 20,000 | $207,400 | 0.01% | no change |
| Scynexis Inc. SCYX | 49,387 | $201,005 | 0.01% | new |
| Personalis Inc. PSNL | 15,000 | $201,000 | 0.01% | -10,000 |
| Q/C Technologies Inc. QCLS | 50,000 | $195,000 | 0.01% | no change |
| Cabaletta Bio Inc. CABA | 50,000 | $155,500 | 0.01% | new |
| Recursion Pharmaceuticals in RXRX | 41,000 | $150,470 | 0.01% | +6,000 |
| Organon & Co. OGN | 10,000 | $135,400 | 0.01% | no change |
| Milestone Pharmaceuticals Inc. (mist) MIST | 100,000 | $134,000 | 0.01% | no change |
| Neuphoria Therapeutics Inc. NEUP | 30,000 | $131,100 | 0.01% | no change |
| Neuronetics Inc. STIM | 100,000 | $130,000 | 0.01% | no change |
| Chemomab Therapeutics Ltd CMMB | 80,000 | $129,600 | 0.01% | no change |
| Voyager Therapeutics Inc. VYGR | 35,000 | $122,500 | 0.01% | no change |
| Entrada Therapeutics Inc. TRDA | 15,500 | $114,080 | 0.01% | -15,000 |
| Veru Inc. VERU | 35,000 | $109,550 | 0.01% | no change |
| Cantor Equity Partners Vii I CAES | 10,000 | $100,900 | 0.00% | new |
| Clene Inc. CLNN | 15,000 | $92,325 | 0.00% | new |
| Vistagen Therapeutics Inc. VTGN | 351,141 | $79,358 | 0.00% | -400,000 |
| Longeveron Inc. LGVN | 108,406 | $76,209 | 0.00% | -91,594 |
| Biomea Fusion Inc. BMEA | 43,420 | $63,827 | 0.00% | no change |
| Mei Pharma Inc. LITS | 67,292 | $62,070 | 0.00% | no change |
| Jasper Therapeutics Inc. JSPR | 140,000 | $58,940 | 0.00% | no change |
| Ardelyx Inc. ARDX | 11,000 | $56,100 | 0.00% | -12,900 |
| Gossamer Bio Inc. GOSS | 212,531 | $34,983 | 0.00% | -75,000 |
| Atyr Pharma Inc. ATYR | 50,685 | $30,249 | 0.00% | no change |
| A Spac III Acquisition Corp. ASPCR | 215,000 | $19,114 | 0.00% | no change |
| Proqr Thrapeutics N V PRQR | 10,000 | $18,600 | 0.00% | no change |
| Best Spac I Acquisition Corp. BSAAR | 100,000 | $16,560 | 0.00% | new |
| Coherus Biosciences Inc. CHRS | 10,366 | $14,512 | 0.00% | no change |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read more
Change is shares against its 13F for the quarter before; the 72 it sold out of are in the box above.Options it reported
| Company | Option | Shares under the options | Value of those shares |
|---|---|---|---|
| iShares Russell 2000 ETF IWM | Puts | 62,500 | $18.8 million |
| SPDR S&P 500 SPY | Puts | 25,000 | $18.7 million |
| SPDR Ser Trust XBI | Puts | 67,400 | $10.7 million |
| Abivax SA ABVX | Calls | 44,400 | $5.9 million |
| Keen Vision Acquisition Corp. KVAC | Calls | 75,000 | $930,000 |
| Amylyx Pharmaceuticals Inc. AMLX | Puts | 40,100 | $720,196 |
| Ultragenyx Pharmaceutical in RARE | Calls | 20,000 | $667,800 |
| Novo Nordisk A/S NVO | Calls | 13,000 | $623,220 |
| Corbus Pharmaceuticals Hldgs CRBP | Calls | 60,000 | $562,800 |
| Solidion Technology Inc. STI | Calls | 13,500 | $125,415 |
10 option lines. A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost; they are not counted in the holdings above.